Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease.
about
Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-κB signaling pathway.Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency.Vitamin D and spondyloarthritis.Vitamin D supplements in chronic kidney disease.Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.
P2860
Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective vitamin D receptor a ...... get in chronic kidney disease.
@en
Selective vitamin D receptor a ...... get in chronic kidney disease.
@nl
type
label
Selective vitamin D receptor a ...... get in chronic kidney disease.
@en
Selective vitamin D receptor a ...... get in chronic kidney disease.
@nl
prefLabel
Selective vitamin D receptor a ...... get in chronic kidney disease.
@en
Selective vitamin D receptor a ...... get in chronic kidney disease.
@nl
P2093
P2860
P50
P921
P356
P1476
Selective vitamin D receptor a ...... rget in chronic kidney disease
@en
P2093
E Martín-Núñez
M L Méndez-Pérez
M Muros-de-Fuentes
V Cazaña-Pérez
V Domínguez-Pimentel
P2860
P304
P356
10.1155/2014/670475
P577
2014-01-06T00:00:00Z